Ocrelizumab for treating primary progressive multiple sclerosis

Supporting evidence

• Evaluation report

• Appraisal consultation committee papers (PDF 22.13 MB)

  Published:

  12 June 2019

• Final appraisal determination 1 committee papers  (PDF 3.4 MB)

  Published:

  12 June 2019

• Final appraisal determination 2 committee papers  (PDF 937 KB)

  Published:

  12 June 2019